Comment on article : "Neutrophil-to-lymphocyte ratio as a serum biomarker associated with community acquired pneumonia"
Identify in a timely manner, through the neutrophil / lymphocyte index, the severity of patients with pneumonia, including that produced by COVID-19, to improve the surveillance-treatment process towards therapeutic success.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:59 |
---|---|
Enthalten in: |
Revista medica del Instituto Mexicano del Seguro Social - 59(2021), 3 vom: 13. Aug., Seite 181 |
Sprache: |
Spanisch |
---|
Weiterer Titel: |
Comentario al artículo: “Índice neutrófilo/linfocito como biomarcador sérico asociado con neumonía adquirida en comunidad” |
---|
Beteiligte Personen: |
Escobar-Munguía, Ignacio [VerfasserIn] |
---|
Themen: |
B-Lymphocytes |
---|
Anmerkungen: |
Date Completed 10.08.2021 Date Revised 10.08.2021 published: Electronic Citation Status MEDLINE |
---|
Förderinstitution / Projekttitel: |
|
---|
PPN (Katalog-ID): |
NLM329020145 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM329020145 | ||
003 | DE-627 | ||
005 | 20231225204208.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||spa c | ||
028 | 5 | 2 | |a pubmed24n1096.xml |
035 | |a (DE-627)NLM329020145 | ||
035 | |a (NLM)34357744 | ||
035 | |a (PII)http://revistamedica.imss.gob.mx/editorial/index.php/revista_medica/article/view/3966 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a spa | ||
100 | 1 | |a Escobar-Munguía, Ignacio |e verfasserin |4 aut | |
245 | 1 | 0 | |a Comment on article |b "Neutrophil-to-lymphocyte ratio as a serum biomarker associated with community acquired pneumonia" |
246 | 3 | 3 | |a Comentario al artículo: “Índice neutrófilo/linfocito como biomarcador sérico asociado con neumonía adquirida en comunidad” |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 10.08.2021 | ||
500 | |a Date Revised 10.08.2021 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Identify in a timely manner, through the neutrophil / lymphocyte index, the severity of patients with pneumonia, including that produced by COVID-19, to improve the surveillance-treatment process towards therapeutic success | ||
650 | 4 | |a Letter | |
650 | 4 | |a B-Lymphocytes | |
650 | 4 | |a Coronavirus Infections | |
650 | 4 | |a Neutrophils | |
650 | 4 | |a Pneumonia | |
650 | 7 | |a Biomarkers |2 NLM | |
773 | 0 | 8 | |i Enthalten in |t Revista medica del Instituto Mexicano del Seguro Social |d 2005 |g 59(2021), 3 vom: 13. Aug., Seite 181 |w (DE-627)NLM156363798 |x 0443-5117 |7 nnns |
773 | 1 | 8 | |g volume:59 |g year:2021 |g number:3 |g day:13 |g month:08 |g pages:181 |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 59 |j 2021 |e 3 |b 13 |c 08 |h 181 |